ArticleTransplant international : official journal of the European Society for Organ Transplantation2022

First Report on Successful Conversion of Long-Term Treatment of Recurrent Atypical Hemolytic Uremic Syndrome With Eculizumab to Ravulizumab in a Renal Transplant Patient.

Ulrich Jehn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.